Navigation Links
Therapure Biopharma Inc. Commissions its Commercial-Scale Lyophilizer
Date:1/28/2010

Freeze-drying of biopharmaceuticals now available at the Company’s Health Canada licensed facility.

Toronto, ON (PRWEB) Jan. 27, 2010 -- Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced that the Company has completing the commissioning and validation of its commercial-scale pharmaceutical-grade freeze dryer and now offers commercial scale freeze drying (lyophilization) for contract manufacturing of biopharmaceuticals.

Lyophilization is used to convert biopharmaceuticals that are manufactured in an unstable liquid format into a stable, dry powder that can be reconstituted to a liquid format for administration to patients. Lyophilized forms of these life-saving products are more easily handled and stable than their liquid forms and therefore lyophilization is commonly used in the manufacture of these products.

“Until today, commercial-scale lyophilization has not been readily available in Canada,” said Mr. Wellner. “The launch of our commercial-scale lyophilizer, combined with our existing aseptic filling capabilities in vials and bags, significantly broadens the service offering we have for clients,” Mr. Wellner continued.

The new lyophilizer has been integrated into Therapure’s existing aseptic vial filling suite. This integrated suite now includes an automated vial filler, vial transporter, and the 75 square foot lyophilizer. All parts of this automated suite are contained within Class 100 clean space and are fully compliant with Health Canada and FDA GMP requirements The fill suite handles fill volumes ranging from 2ml to 200ml in glass vials with rubber stoppers and capped, and is capable of batch sizes ranging from 35,000 units per shift for smaller vials to 3,000 units per shift for larger vials.

About Therapure Biopharma:

Therapure Biopharma Inc. is an integrated biopharmaceutical co
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
2. Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
3. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
4. Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry
5. Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer
6. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
9. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
11. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 If you have ... difficulty breathing, you probably wished you had an arsenal ... COPD, cystic fibrosis, and other breathing disorders. Currently, the ... and avoiding triggers, but other common treatments do exist. ... conference in San Antonio, TX, 34 asthma educators responded ...
(Date:12/19/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Gliquidone manufacturers and is a valuable source of ... the industry. , Firstly, the report provides a basic ... manufacturing technology. Then, the report explores the international and ...
(Date:12/19/2014)... A new study suggests a possible link between certain ... night sweats -- and higher rates of hip fractures ... menopause, affecting about 60 percent of women. The hormonal ... they then face a higher risk of weakened bones ... moderate or severe menopausal symptoms are more likely to ...
(Date:12/19/2014)... (HealthDay News) -- Traveling through the same U.S. airport ... three others within a four-hour time span, illustrating just ... shows. "The exposures in this report were not ... international terminal, highlighting the fact that measles is highly ... infectious disease specialist at the U.S. Centers for Disease ...
(Date:12/17/2014)... 2014 Dr. Myo Nwe is the co-author ... of the Futureā€ and co-founder of the Ace Medical Weight ... Nwe takes a broad look at the industry of weight ... scientific scrutiny. On film and in television shows, however, she ... the social aspects and played for basic laughs, which she ...
Breaking Medicine News(10 mins):Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2
... Ind., Jan. 20 Conseco, Inc. (NYSE: ... a stockholder rights plan,designed to protect stockholder value by ... tax net operating loss carryforwards under,Section 382 of the ... value,of those tax assets upon an "ownership change." ...
... purchased raw milk from the Conestoga Valley Dairy Farm ... to the risk of Salmonella contamination, Agriculture Secretary Dennis ... to kill disease-causing bacteria or homogenized. Pennsylvania farms selling ... samples tested in a laboratory due to the health ...
... Foundation to Host Five Cancer Fighters on January 30th ... Jan. 20 Lillians(TM), The Hippest Shoppe in Town(R) ... announced that it will postpone "the dance," its annual ... until Friday, Oct. 23, 2009, at the Medina Entertainment ...
... enterprise WLAN solution for point-of-care, voice and AeroScout asset ... Inc. (NYSE: MOT ) today announced ... LAN (WLAN) solution to support several of its current ... a 680-bed facility providing quality patient care in Montreal, ...
... other chemicals boost their odds of respiratory trouble, ... -- Frequent exposure to hospital cleaning products and ... to a U.S. study that included 3,650 Texan ... researchers found that nurses regularly exposed to cleaning ...
... MassMutual,s Retirement Services Division has added three new ... third-party administrators (TPA). The new TPA relationship managers ... investment change processing, product and service education and ... platform. Karen Buoniconti joined MassMutual,s TPA ...
Cached Medicine News:Health News:Conseco Adopts Stockholder Rights Plan 2Health News:Conseco Adopts Stockholder Rights Plan 3Health News:Conseco Adopts Stockholder Rights Plan 4Health News:Conseco Adopts Stockholder Rights Plan 5Health News:Lillians(TM) Postpones 'The Dance' Fundraising Event; New Date Is October 23, 2009 2Health News:Montreal Jewish General Hospital Improves Care and Reduces Costs With Motorola's Enterprise Mobility Solution 2Health News:Montreal Jewish General Hospital Improves Care and Reduces Costs With Motorola's Enterprise Mobility Solution 3Health News:Cleaning Products Up Nurses' Asthma Risk 2Health News:MassMutual Retirement Services Appoints Three New TPA Relationship Managers 2
(Date:12/19/2014)... 18, 2014 Radiology information ... is used to store, manipulate, and distribute patient ... patient tracking and scheduling system, result reporting, and ... with HIS and other databases improves the hospital ... patient scheduling, patient list management, radiology department workflow ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... the United States will increase ... Growth will be primarily driven by expansion in the ... direct energy devices will be increasingly adopted due to ... launched. Other key findings from Decision Resources ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3
... LEUVEN, Belgium, September 29 , - Results ... ThromboGenics NV (Euronext Brussels: THR), a biotechnology company,focused ... and cancer,announces positive results from its MITI IV ... efficacy of microplasmin when administered,intravenously to acute stroke ...
... Dikembe Mutombo Foundation to improve healthcare,system in the ... Sept. 25 The Clinton Global,Initiative recognized BD ... a,leading global medical technology company, for its commitment ... system monitoring and,healthcare worker safety at the Biamba ...
Cached Medicine Technology:ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 2ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 3ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin 4Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft....
Autoclavable reusable pencil for Aaron 800 & 1200 - comes with generator or 1/box....
Disposable 1 1/4" Tungsten Micro Needle, Ins., Straight...
Split adult return electrode grounding pad with 2.8 m cable, 50/box....
Medicine Products: